Literature DB >> 7790979

The effect of diagnosing Alzheimer's disease on frequency of physician visits: a case-control study.

W C McCormick1, W A Kukull, G van Belle, J D Bowen, L Teri, E B Larson.   

Abstract

OBJECTIVE: Two groups of elderly subjects were studied to see whether patterns of visits to physicians changed after one group received the diagnosis of Alzheimer's disease.
DESIGN: Case-control study.
SETTING: Health maintenance organization (HMO). PATIENTS/PARTICIPANTS: Two groups of ambulatory subjects (mean age 77 years) were enrolled from an HMO population for this case-control study: 120 cases had probable Alzheimer's disease diagnosed at enrollment, and another 120 cognitively intact controls with similar comorbidity were enrolled after being frequency-matched for age and gender. Exclusion criteria were nursing home admission and death during the study period.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Medical records were examined for a four-year period: two years prior to and two years following enrollment and diagnosis. Physician visits declined slightly after enrollment for the persons receiving the diagnosis of Alzheimer's disease [17.5/2 years prior vs 16.5/2 years after (NS)], whereas visits increased over time for the controls [13.7/2 vs 16.3/2 (p < 0.05)], hence the rates were similar after enrollment [16.5 vs 16.3 (NS)]. The proportion of subjects with fewer visits during the period after enrollment was higher among the cases than it was among the controls [54% vs 37%; odds ratio = 2.0 (95% confidence interval = 1.6, 3.1)]. Hospitalizations and emergency department use did not change significantly after enrollment.
CONCLUSIONS: Physician visit frequency was high before, then decreased after, demented patients received their diagnosis, approaching the frequency in a control population without dementia. This phenomenon cannot be accounted for by nursing home placement, comorbidity, or mortality. Increased hospitalization and emergency department use did not ensue after diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 7790979     DOI: 10.1007/bf02600253

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  27 in total

1.  Should patients with Alzheimer's disease be told their diagnosis?

Authors:  M A Drickamer; M S Lachs
Journal:  N Engl J Med       Date:  1992-04-02       Impact factor: 91.245

2.  University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987-1988.

Authors:  E B Larson; W A Kukull; L Teri; W McCormick; M Pfanschmidt; G van Belle; M Sumi
Journal:  Aging (Milano)       Date:  1990-12

3.  Cognitive deterioration in Alzheimer's disease: behavioral and health factors.

Authors:  L Teri; J P Hughes; E B Larson
Journal:  J Gerontol       Date:  1990-03

4.  Are Alzheimer patients healthier than others?

Authors: 
Journal:  J Am Geriatr Soc       Date:  1989-05       Impact factor: 5.562

5.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

6.  Symptom patterns and comorbidity in the early stages of Alzheimer's disease.

Authors:  W C McCormick; W A Kukull; G van Belle; J D Bowen; L Teri; E B Larson
Journal:  J Am Geriatr Soc       Date:  1994-05       Impact factor: 5.562

7.  Recognition of dementia among medical patients.

Authors:  R P Roca; L E Klein; S M Kirby; J C McArthur; G B Vogelsang; M F Folstein; C R Smith
Journal:  Arch Intern Med       Date:  1984-01

8.  Causes of death associated with Alzheimer disease: variation by level of cognitive impairment before death.

Authors:  W A Kukull; D E Brenner; C E Speck; D Nochlin; J Bowen; W McCormick; L Teri; M L Pfanschmidt; E B Larson
Journal:  J Am Geriatr Soc       Date:  1994-07       Impact factor: 5.562

Review 9.  On the uses of registries for Alzheimer disease.

Authors:  J P Hughes; G van Belle; W Kukull; E B Larson; L Teri
Journal:  Alzheimer Dis Assoc Disord       Date:  1989       Impact factor: 2.703

Review 10.  Labelling in hypertension: a review of the behavioural and psychological consequences.

Authors:  L A Macdonald; D L Sackett; R B Haynes; D W Taylor
Journal:  J Chronic Dis       Date:  1984
View more
  5 in total

Review 1.  Methodology, design, and analytic techniques to address measurement of comorbid disease.

Authors:  Timothy L Lash; Vincent Mor; Darryl Wieland; Luigi Ferrucci; William Satariano; Rebecca A Silliman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-03       Impact factor: 6.053

Review 2.  North of England evidence based guidelines development project: guideline for the primary care management of dementia.

Authors:  M Eccles; J Clarke; M Livingstone; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-09-19

3.  Physician visit frequency in Alzheimer's disease.

Authors:  R A Murden
Journal:  J Gen Intern Med       Date:  1995-09       Impact factor: 5.128

4.  Comorbidity in aging and dementia: scales differ, and the difference matters.

Authors:  Soo Borson; James M Scanlan; Mary Lessig; Shaune DeMers
Journal:  Am J Geriatr Psychiatry       Date:  2010-11       Impact factor: 4.105

5.  Medicare expenditures attributable to dementia.

Authors:  Lindsay White; Paul Fishman; Anirban Basu; Paul K Crane; Eric B Larson; Norma B Coe
Journal:  Health Serv Res       Date:  2019-03-13       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.